Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 14, 2021

SELL
$42.51 - $63.78 $7.23 Million - $10.8 Million
-170,000 Closed
0 $0
Q4 2020

Mar 19, 2021

BUY
$45.3 - $60.27 $7.7 Million - $10.2 Million
170,000 New
170,000 $9.61 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Cloud Alpha Capital Management Limited Portfolio

Follow Cloud Alpha Capital Management Limited and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cloud Alpha Capital Management Limited, based on Form 13F filings with the SEC.

News

Stay updated on Cloud Alpha Capital Management Limited with notifications on news.